Nanoparticle injection reprograms NK immune cells to fight cancer and autoimmune disorders

Image: Phys.org
ad slot · in-content video 16:9
Coverage
More coverage
- MIT engineers have developed a new way to program natural killer (NK) immune cells to target cancerous T cells or T cells that have become autoreactive, leading to diseases such as lymphoma and autoimmune hepatitis.